cognitive function

Brain and Mood Changes Over 2 Years in Healthy Controls and Adults With Heart Failure and Ischaemic Heart Disease.

Brain and mood changes over 2 years in healthy controls and adults with heart failure and ischaemic heart disease.

Eur J Heart Fail. 2013 Mar 4;
Almeida OP, Garrido GJ, Etherton-Beer C, Lautenschlager NT, Arnolda L, Alfonso H, Flicker… Continue reading →

Current Evidence for the Clinical Use of Long-Chain Polyunsaturated N-3 Fatty Acids to Prevent Age-Related Cognitive Decline and Alzheimer’s Disease.

Current evidence for the clinical use of long-chain polyunsaturated N-3 Fatty acids to prevent age-related cognitive decline and Alzheimer’s disease.

J Nutr Health Aging. 2013; 17(3): 240-51
Dacks PA, Shineman DW, Fillit HM

An NIH State of the Science… Continue reading →

The Ataxia Telangiectasia Mutated Kinase Pathway Regulates IL-23 Expression by Human Dendritic Cells.

The Ataxia Telangiectasia Mutated Kinase Pathway Regulates IL-23 Expression by Human Dendritic Cells.

J Immunol. 2013 Mar 4;
Wang Q, Franks HA, Lax SJ, El Refaee M, Malecka A, Shah S, Spendlove I, Gough MJ, Seedhouse C, Madhusudan S,… Continue reading →

[Influence of Methylenetetrahydrofolate Reductase Gene Polymorphisms on Antidepressant Response].

[Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Feb; 30(1): 26-30
Sun X, Zhang Z, Shi Y, Xu Z, Pu M, Geng L

To assess the influence of polymorphisms… Continue reading →

Effectiveness of a Randomized School-Based Intervention Involving Families and Teachers to Prevent Excessive Weight Gain Among Adolescents in Brazil.

Effectiveness of a Randomized School-Based Intervention Involving Families and Teachers to Prevent Excessive Weight Gain among Adolescents in Brazil.

PLoS One. 2013; 8(2): e57498
Cunha DB, de Souza Bda S, Pereira RA, Sichieri R

To evaluate the effectiveness of… Continue reading →

Discovery of Drug Resistance Biomarker Could Improve Cancer Treatment.

Discovery of drug resistance biomarker could improve cancer treatment.

Pharmacogenomics. 2013 Jan; 14(2): 125

HubMed – drug

 

Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.

Cerebrum. 2012 11; 2012: 14
Rahn K, Slusher B, Kaplin A… Continue reading →

Gene-Environment Interactions in Major Depressive Disorder.

Gene-environment interactions in major depressive disorder.

Can J Psychiatry. 2013 Feb; 58(2): 76-83
Klengel T, Binder EB

Family, twin, and epidemiologic studies have suggested that both genes and environment are important risk factors for the development of major depressive… Continue reading →

Diagnostic Issues of Binge Eating in Eating Disorders.

Diagnostic Issues of Binge Eating in Eating Disorders.

Eur Eat Disord Rev. 2013 Feb 26;
Birgegård A, Clinton D, Norring C

BACKGROUND: Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for eating disorders (EDs) are problematic and due… Continue reading →

Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing.

Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing.

PLoS One. 2013; 8(2): e57140
Kandeel M, Kitade Y

RNA interference (RNAi) is a highly specialized process of protein-siRNA interaction… Continue reading →